These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 497555)
1. Effects of dopamine receptor agonists and antagonists in the rat nucleus acumbens [proceedings]. Freedman SB; Wait CP; Woodruff GN Br J Pharmacol; 1979 Nov; 67(3):430P-431P. PubMed ID: 497555 [No Abstract] [Full Text] [Related]
2. A demonstration of the ability of apomorphine to act on dopamine receptors on nerve terminals in the nucleus accumbens to reduce locomotor hyperactivity [proceedings]. Costall B; Hui SC; Naylor RJ Br J Pharmacol; 1979 Nov; 67(3):475P-476P. PubMed ID: 497587 [No Abstract] [Full Text] [Related]
3. Cholinergic potentiation of neuroleptic effects in the nucleus accumbens. Vance MA; Blumberg JB Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):345-8. PubMed ID: 6136070 [TBL] [Abstract][Full Text] [Related]
4. On the structural requirements for dopamine-like activity in homogenates of rat nucleus accumbens [proceedings]. Munday KA; Poat JA; Watling KJ; Woodruff GN Br J Pharmacol; 1977 Sep; 61(1):150P-151P. PubMed ID: 912199 [No Abstract] [Full Text] [Related]
5. Activation of accumbal and striatal dopamine autoreceptors by some ergoline derivatives. Gundlach AL; Christie MJ; Beart PM Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):149-52. PubMed ID: 3992029 [TBL] [Abstract][Full Text] [Related]
6. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens. Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716 [TBL] [Abstract][Full Text] [Related]
7. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens. Kalivas PW; Richardson-Carlson R; Duffy P J Pharmacol Exp Ther; 1986 Sep; 238(3):1126-31. PubMed ID: 3755755 [TBL] [Abstract][Full Text] [Related]
8. Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity. Van Ree JM; Wolterink G Eur J Pharmacol; 1981 Jun; 72(1):107-11. PubMed ID: 7262189 [No Abstract] [Full Text] [Related]
9. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats]. Kudrin VS; Hetey L; Morgenshtern R; RaevskiÄ KS; Olssner W Farmakol Toksikol; 1987; 50(2):16-20. PubMed ID: 2884129 [TBL] [Abstract][Full Text] [Related]
10. Dopamine-sensitive adenylate cyclase in homogenates of rat nucleus accumbens: structure-activity studies and effects of agonists and antagonists. Watling KJ; Woodruff GN; Poat JA Eur J Pharmacol; 1979 Jun; 56(1-2):45-9. PubMed ID: 38129 [TBL] [Abstract][Full Text] [Related]
11. (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity. Cools AR; Oosterloo SK J Neural Transm Suppl; 1983; 18():181-8. PubMed ID: 6308148 [TBL] [Abstract][Full Text] [Related]
12. Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health. Wray SR; Melville GN; Wenger T; Louden D West Indian Med J; 1984 Jun; 33(2):106-16. PubMed ID: 6541399 [No Abstract] [Full Text] [Related]
13. Chronic cocaine administration induces opposite changes in dopamine receptors in the striatum and nucleus accumbens. Goeders NE; Kuhar MJ Alcohol Drug Res; 1987; 7(4):207-16. PubMed ID: 2950865 [TBL] [Abstract][Full Text] [Related]
14. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related]
15. Suppression of exploratory locomotor activity in the rat by the local application of 3-PPP enantiomers into the nucleus accumbens. Svensson L; Ahlenius S Eur J Pharmacol; 1983 Apr; 88(4):393-7. PubMed ID: 6861878 [TBL] [Abstract][Full Text] [Related]
16. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat. Van den Bos R; Cools AR; Ogren SO Acta Physiol Scand; 1989 Dec; 137(4):547-8. PubMed ID: 2557730 [No Abstract] [Full Text] [Related]
17. Activation of excitatory amino acid receptors may mediate the folate-induced stimulation of locomotor activity after bilateral injection into the rat nucleus accumbens. Stephens RL; Lee T; Boldry R; Uretsky NJ J Pharmacol Exp Ther; 1986 Dec; 239(3):627-33. PubMed ID: 3025414 [TBL] [Abstract][Full Text] [Related]
18. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat. Van den Bos R; Cools AR; Ogren SO Acta Physiol Scand; 1990 Mar; 138(3):423-4. PubMed ID: 2158210 [No Abstract] [Full Text] [Related]
19. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens. Vezina P; Blanc G; Glowinski J; Tassin JP Synapse; 1994 Feb; 16(2):104-12. PubMed ID: 8197574 [TBL] [Abstract][Full Text] [Related]
20. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity. Lai H; Carino MA; Sperry R; Horita A J Pharm Pharmacol; 1981 Apr; 33(4):252-4. PubMed ID: 6115914 [No Abstract] [Full Text] [Related] [Next] [New Search]